Edema News and Research

RSS
Edema means swelling caused by fluid in your body's tissues. It usually occurs in the feet, ankles and legs, but it can involve your entire body.
XOMA 052 reduces adverse consequences that lead to development of congestive heart failure

XOMA 052 reduces adverse consequences that lead to development of congestive heart failure

Abbott's sNDA for new six-month 45-mg formulation of Lupron  Depot: FDA accepts for review

Abbott's sNDA for new six-month 45-mg formulation of Lupron Depot: FDA accepts for review

Watson Pharmaceuticals' TRELSTAR receives FDA approval for treatment of advanced prostate cancer

Watson Pharmaceuticals' TRELSTAR receives FDA approval for treatment of advanced prostate cancer

People with varicose veins should seek professional consultation

People with varicose veins should seek professional consultation

QLT announces results from Phase II clinical trials and device study for PPDS

QLT announces results from Phase II clinical trials and device study for PPDS

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

JAAD publishes Phase III data evaluating safety and efficacy of imiquimod in patients with AK

JAAD publishes Phase III data evaluating safety and efficacy of imiquimod in patients with AK

Closing small bowel stomas: Minimal delay optimal

Closing small bowel stomas: Minimal delay optimal

Varicose veins may signal potential dangerous blood clots

Varicose veins may signal potential dangerous blood clots

Nanoparticle growing in popularity as bactericidal agent shown to be toxic to fish: Study

Nanoparticle growing in popularity as bactericidal agent shown to be toxic to fish: Study

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

Data from FAME Phase 3 study for Iluvien presented at Angiogenesis 2010

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Data demonstrating effectiveness of KALBITOR to treat acute HAE presented at AAAAI 2010 Annual Meeting

Data demonstrating effectiveness of KALBITOR to treat acute HAE presented at AAAAI 2010 Annual Meeting

Phase III study results of Merck's allergy immunotherapy tablet

Phase III study results of Merck's allergy immunotherapy tablet

EMA accepts the filing of Lux Biosciences' MAA for Luveniq

EMA accepts the filing of Lux Biosciences' MAA for Luveniq

Corneal transplant surgery: DSAEK leads to greater cell loss overall than PKP

Corneal transplant surgery: DSAEK leads to greater cell loss overall than PKP

C1-INH replacement therapy effective for treating acute swelling attacks in HAE

C1-INH replacement therapy effective for treating acute swelling attacks in HAE

Canyon Pharmaceuticals announces the availability of Iprivask inhibitor for prevention of DVT

Canyon Pharmaceuticals announces the availability of Iprivask inhibitor for prevention of DVT

Quark Pharmaceuticals commences dosing in clinical study of QPI-1007 for NAION

Quark Pharmaceuticals commences dosing in clinical study of QPI-1007 for NAION

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.